Q2 2017 Holdings
Filed 2017-08-14 | 21 holdings | $66.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $39.3M | 3,244,046 | 59.4% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $26.1M | 1,814,289 | 39.4% |
| Inogen Inc(INGN) | COM | 45780L104 | $338.7K | 3,549,320 | 0.5% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $72.6K | 3,033,504 | 0.1% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $47.2K | 1,553,937 | 0.1% |
| Spectranetics Corp | COM | 84760C107 | $45.6K | 1,187,917 | 0.1% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $44.7K | 1,534,664 | 0.1% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $38.1K | 2,031,562 | 0.1% |
| Flexion Therapeutics Inc | COM | 33938J106 | $30.3K | 1,500,000 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $24.4K | 2,326,544 | 0.0% |
| Obseva SA | COM | H5861P103 | $23.2K | 2,710,760 | 0.0% |
| Merus N V | COM | N5749R100 | $22.4K | 1,410,417 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $21.4K | 2,901,927 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $18.8K | 592,794 | 0.0% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $10.7K | 1,351,972 | 0.0% |
| Invuity Inc | COM NEW | 46187J205 | $9.9K | 1,363,848 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $8.6K | 740,740 | 0.0% |
| Wright MED Group N V | RIGHT 03/01/2019 | N96617126 | $6.7K | $4,622,032 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $3.6K | 223,317 | 0.0% |
| HTG Molecular Diagnostics Inc | COM | 40434H104 | $3.3K | 1,230,399 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $402 | 127,563 | 0.0% |